Concurrent naxitamab and lorlatinib in a patient with refractory high-risk neuroblastoma: a case report.
Saved in:
| Title: | Concurrent naxitamab and lorlatinib in a patient with refractory high-risk neuroblastoma: a case report. |
|---|---|
| Authors: | Aydin S; Pediatric Hematology and Oncology, Antalya Training and Research Hospital, Antalya, Türkiye., Oz A; Pediatric Hematology and Oncology, Antalya Training and Research Hospital, Antalya, Türkiye. |
| Source: | Frontiers in oncology [Front Oncol] 2026 Mar 23; Vol. 16, pp. 1790294. Date of Electronic Publication: 2026 Mar 23 (Print Publication: 2026). |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
